{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T14:40:19Z","timestamp":1791038419731,"version":"4.1.0"},"reference-count":73,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Immunology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/j.clim.2021.108819","type":"journal-article","created":{"date-parts":[[2021,8,4]],"date-time":"2021-08-04T03:19:37Z","timestamp":1628047177000},"page":"108819","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"special_numbering":"C","title":["Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review"],"prefix":"10.1016","volume":"230","author":[{"given":"Yiyun","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0005","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.iac.2006.08.002","article-title":"Acquired deficiency of the inhibitor of the first complement component: presentation, diagnosis, course, and conventional management","volume":"26","author":"Zingale","year":"2006","journal-title":"Immunol. Allergy Clin. N. Am."},{"issue":"3","key":"10.1016\/j.clim.2021.108819_bb0010","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.iac.2017.03.002","article-title":"Acquired C1 inhibitor deficiency","volume":"37","author":"Otani","year":"2017","journal-title":"Immunol. Allergy Clin. N. Am."},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0015","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3324\/haematol.10769","article-title":"Lymphoproliferative disease and acquired C1 inhibitor deficiency","volume":"92","author":"Castelli","year":"2007","journal-title":"Haematologica"},{"issue":"6","key":"10.1016\/j.clim.2021.108819_bb0020","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1111\/bjh.13908","article-title":"High prevalence of splenic marginal zone lymphoma among patients with acquired C1 inhibitor deficiency","volume":"172","author":"Castelli","year":"2016","journal-title":"Br. J. Haematol."},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0025","doi-asserted-by":"crossref","first-page":"256","DOI":"10.3109\/07853890.2016.1162909","article-title":"Hereditary and acquired C1-inhibitor-dependent angioedema: from pathophysiology to treatment","volume":"48","author":"Zeerleder","year":"2016","journal-title":"Ann. Med."},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0030","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/all.12380","article-title":"Classification, diagnosis, and approach to treatment for angioedema: consensus report from the hereditary angioedema international working group","volume":"69","author":"Cicardi","year":"2014","journal-title":"Allergy"},{"issue":"6","key":"10.1016\/j.clim.2021.108819_bb0035","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1080\/14712598.2019.1595581","article-title":"Current and emerging biologics for the treatment of hereditary angioedema","volume":"19","author":"Perego","year":"2019","journal-title":"Expert. Opin. Biol. Ther."},{"issue":"3","key":"10.1016\/j.clim.2021.108819_bb0040","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.critrevonc.2013.02.004","article-title":"Acquired C1-inhibitor deficiency and lymphoproliferative disorders: a tight relationship","volume":"87","author":"Castelli","year":"2013","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"3","key":"10.1016\/j.clim.2021.108819_bb0045","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1046\/j.1365-2249.1996.d01-866.x","article-title":"Relevance of lymphoproliferative disorders and of anti-C1 inhibitor autoantibodies in acquired angio-oedema","volume":"106","author":"Cicardi","year":"1996","journal-title":"Clin. Exp. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0050","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1097\/01.md.0000085055.63483.09","article-title":"Autoantibodies and lymphoproliferative diseases in acquired C1-inhibitor deficiencies","volume":"82","author":"Cicardi","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0055","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jaip.2016.12.032","article-title":"Diagnosis, course, and management of angioedema in patients with acquired C1-inhibitor deficiency","volume":"5","author":"Zanichelli","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"33","key":"10.1016\/j.clim.2021.108819_bb0060","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004363","article-title":"A nationwide study of acquired C1-inhibitor deficiency in France: characteristics and treatment responses in 92 patients","volume":"95","author":"Gobert","year":"2016","journal-title":"Medicine (Baltimore)"},{"issue":"05","key":"10.1016\/j.clim.2021.108819_bb0065","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1160\/TH06-01-0062","article-title":"Deep venous thrombosis associated with acquired angioedema type II in a patient heterozygous for the mutation of factor V Leiden: effective treatment and follow-up for four years","volume":"95","author":"Sz\u00e9plaki","year":"2006","journal-title":"Thromb. Haemost."},{"issue":"8","key":"10.1016\/j.clim.2021.108819_bb0070","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amjmed.2005.09.018","article-title":"Rituximab-induced elimination of acquired angioedema due to C1-inhibitor deficiency","volume":"119","author":"Levi","year":"2006","journal-title":"Am. J. Med."},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0075","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1136\/jcp.2006.041350","article-title":"Falsely normal C4 in a case of acquired C1 esterase inhibitor deficiency","volume":"60","author":"McLean-Tooke","year":"2006","journal-title":"J. Clin. Pathol."},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0080","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2500\/aap.2007.28.2973","article-title":"C1-esterase inhibitor autoantibodies in a patient with acute tongue swelling","volume":"28","author":"Lin","year":"2007","journal-title":"Allergy Asthma. Proc."},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0085","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1742-6723.2006.00930.x","article-title":"Acute upper airway obstruction from acquired angioedema","volume":"19","author":"Cheng","year":"2007","journal-title":"Emerg. Med. Australas."},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0090","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.tripleo.2006.11.015","article-title":"Acquired angioedema in non-Hodgkin\u2019s lymphoma","volume":"103","author":"Healy","year":"2007","journal-title":"Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod."},{"issue":"9","key":"10.1016\/j.clim.2021.108819_bb0095","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1111\/j.1445-5994.2007.01459.x","article-title":"Angioedema, lymphoproliferative disorder and angiotensin-converting enzyme inhibitors: masking of diagnosis by corticosteroids","volume":"37","author":"Hissaria","year":"2007","journal-title":"Intern. Med. J."},{"issue":"2","key":"10.1016\/j.clim.2021.108819_bb0100","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1159\/000113521","article-title":"Acquired angioedema associated with primary antiphospholipid syndrome in a patient with antithrombin III deficiency","volume":"146","author":"Sz\u00e9plaki","year":"2008","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"3","key":"10.1016\/j.clim.2021.108819_bb0105","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/0961203307087405","article-title":"Successful use of rituximab in acquired C1 inhibitor deficiency secondary to Sj\u00f6gren\u2019s syndrome","volume":"17","author":"S\u00e1nchez-Cano","year":"2008","journal-title":"Lupus"},{"key":"10.1016\/j.clim.2021.108819_bb0110","series-title":"Helicobacter Pylori Infection","volume":"3","author":"Mukeba","year":"2009"},{"issue":"2","key":"10.1016\/j.clim.2021.108819_bb0115","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1179\/acb.2010.024","article-title":"Vanishing tumour of the colon ascendens due to acquired type II C1- inhibitor deficiency","volume":"65","author":"Ebo","year":"2010","journal-title":"Acta Clin. Belg."},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0120","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2500\/aap.2010.31.3361","article-title":"Acquired angioedema: autoantibody associations and C1q utility as a diagnostic tool","volume":"31","author":"Breitbart","year":"2010","journal-title":"Allergy Asthma. Proc."},{"issue":"2","key":"10.1016\/j.clim.2021.108819_bb0125","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2340\/00015555-1055","article-title":"Rapid resolution of erythema marginatum after icatibant in acquired angioedema","volume":"91","author":"Bygum","year":"2011","journal-title":"Acta Derm Venerol"},{"issue":"6","key":"10.1016\/j.clim.2021.108819_bb0130","doi-asserted-by":"crossref","first-page":"733","DOI":"10.2340\/00015555-1157","article-title":"Acquired angioedema responding to rituximab","volume":"91","author":"Hassan","year":"2011","journal-title":"Acta Derm Venerol"},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0135","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1177\/039463201102400433","article-title":"Acquired angioedema with C1 inhibitor deficiency associated with anticardiolipin antibodies","volume":"24","author":"Di Leo","year":"2011","journal-title":"Int. J. Immunopathol. Pharmacol."},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0140","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1752-1947-5-62","article-title":"Isolated angioedema of the bowel due to C1 esterase inhibitor deficiency: a case report and review of literature","volume":"5","author":"Kothari","year":"2011","journal-title":"J. Med. Case Rep."},{"issue":"16","key":"10.1016\/j.clim.2021.108819_bb0145","doi-asserted-by":"crossref","first-page":"e151","DOI":"10.1200\/JCO.2011.38.9957","article-title":"Acquired angioedema and marginal zone lymphoma","volume":"30","author":"Lam","year":"2012","journal-title":"J. Clin. Oncol."},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0150","first-page":"178","article-title":"Acquired C1-inhibitor deficiency: a case report","volume":"44","author":"Galdi","year":"2012","journal-title":"Eur Ann Allergy Clin Immunol"},{"issue":"8","key":"10.1016\/j.clim.2021.108819_bb0155","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1111\/j.1398-9995.2012.02853.x","article-title":"Icatibant treatment for acquired C1-inhibitor deficiency: a real-world observational study","volume":"67","author":"Zanichelli","year":"2012","journal-title":"Allergy"},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0160","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1007\/s10875-012-9691-2","article-title":"Acquired C1-inhibitor deficiency: 7 patients treated with rituximab","volume":"32","author":"on behalf of the French National Reference Center for Angioedema (CREAK)","year":"2012","journal-title":"J. Clin. Immunol."},{"issue":"2","key":"10.1016\/j.clim.2021.108819_bb0165","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1159\/000351452","article-title":"Acquired angioedema - occurrence, clinical features and associated disorders in a Danish Nationwide patient cohort","volume":"162","author":"Bygum","year":"2013","journal-title":"Int. Arch. Allergy Immunol."},{"key":"10.1016\/j.clim.2021.108819_bb0170","first-page":"292","article-title":"A patient with chronic lymphocytic leukemia and acquired angioedema: correlation of clinical and biochemical response to CLL therapy","volume":"7","author":"Mohyuddin","year":"2013","journal-title":"Ecancermedicalscience"},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0175","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.anai.2012.10.013","article-title":"Acquired angioedema with raised serum tryptase","volume":"110","author":"Fok","year":"2013","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0180","doi-asserted-by":"crossref","first-page":"72","DOI":"10.2500\/aap.2013.34.3620","article-title":"Ecallantide for treatment of acute attacks of acquired C1 esterase inhibitor deficiency","volume":"34","author":"Patel","year":"2013","journal-title":"Allergy Asthma. Proc."},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0185","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/MEG.0b013e32835c94ff","article-title":"Small bowel angioedema due to acquired C1 inhibitor deficiency: a case report and overview","volume":"25","author":"Oostergo","year":"2013","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"issue":"3","key":"10.1016\/j.clim.2021.108819_bb0190","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.anai.2013.12.024","article-title":"Acquired C1 inhibitor deficiency: should we monitor for associated antibody deficiency?","volume":"112","author":"Tohani","year":"2014","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0195","first-page":"315","article-title":"Successful rituximab B lymphocyte depletion therapy for angioedema due to acquired C1 inhibitor protein deficiency: association with reduced C1 inhibitor protein autoantibody titers","volume":"16","author":"Dreyfus","year":"2014","journal-title":"Isr. Med. Assoc. J."},{"issue":"2","key":"10.1016\/j.clim.2021.108819_bb0200","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1016\/j.jaci.2014.03.008","article-title":"Short-term prophylaxis in a patient with acquired C1-INH deficiency","volume":"134","author":"Farkas","year":"2014","journal-title":"J. Allergy Clin. Immunol."},{"issue":"9","key":"10.1016\/j.clim.2021.108819_bb0205","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1002\/ajh.23763","article-title":"Searching for the leak: rituximab prophylaxis in acquired angioedema","volume":"89","author":"Shepshelovich","year":"2014","journal-title":"Am. J. Hematol."},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0210","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1752-1947-8-28","article-title":"Fulminant systemic capillary leak syndrome due to C1 inhibitor deficiency complicating acute dermatomyositis: a case report","volume":"8","author":"Gradwohl-Matis","year":"2014","journal-title":"J. Med. Case Rep."},{"key":"10.1016\/j.clim.2021.108819_bb0215","article-title":"Rituximab therapy in a patient with low grade B-cell lymphoproliferative disease and concomitant acquired angioedema","volume":"165","author":"Williams","year":"2014","journal-title":"JAA"},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0220","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.anai.2014.10.008","article-title":"Benefits of hydroxychloroquine in the treatment of a patient with angioedema due to acquired C1 inhibitor deficiency","volume":"114","author":"Vincent","year":"2015","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0225","first-page":"349","article-title":"Acquired C1 esterase inhibitor deficiency in a marginal zone lymphoma patient treated with rituximab","volume":"20","author":"Ates","year":"2015","journal-title":"J. BUON."},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0230","doi-asserted-by":"crossref","first-page":"101","DOI":"10.7861\/clinmedicine.15-1-101","article-title":"Lesson of the month 2: the limitations of steroid therapy in bradykinin-mediated angioedema attacks","volume":"15","author":"Ismail","year":"2015","journal-title":"Clin. Med."},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0235","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1111\/trf.13462","article-title":"Nanofiltrated C1-esterase-inhibitor in the prophylactic treatment of bradykinin-mediated angioedema: angioedema prophylaxis with C1-inhibitor","volume":"56","author":"Greve","year":"2016","journal-title":"Transfusion"},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0240","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.anai.2016.03.003","article-title":"Rituximab in a patient with splenic marginal zone lymphoma and acquired angioedema","volume":"116","author":"Motosue","year":"2016","journal-title":"Ann. Allergy Asthma Immunol."},{"issue":"9","key":"10.1016\/j.clim.2021.108819_bb0245","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.3109\/10428194.2015.1131273","article-title":"Acquired C1 esterase inhibitor deficiency in lymphomas: prevalence, symptoms, and response to treatment","volume":"57","author":"Bekos","year":"2016","journal-title":"Leuk. Lymphoma"},{"issue":"5","key":"10.1016\/j.clim.2021.108819_bb0250","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/j.jaip.2016.02.019","article-title":"Cases of acquired C1 inhibitor deficiency treated with rituximab","volume":"4","author":"Doshi","year":"2016","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0255","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.anai.2017.07.032","article-title":"Clinical and biological response to rituximab treatment in 3 patients with acquired C1-inhibitor deficiency","volume":"119","author":"Busse","year":"2017","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.clim.2021.108819_bb0260","first-page":"1","article-title":"Refractory abdominal pain in a patient with chronic lymphocytic leukemia: be wary of acquired angioedema due to C1 esterase inhibitor deficiency","volume":"2018","author":"Abdulkareem","year":"2018","journal-title":"Case Rep. Hematol."},{"issue":"2","key":"10.1016\/j.clim.2021.108819_bb0265","first-page":"E14","article-title":"Atypical presentation of acquired angioedema","volume":"101","author":"Baird","year":"2018","journal-title":"Cutis"},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0270","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13223-018-0246-9","article-title":"Case report presenting the diagnostic challenges in a patient with recurrent acquired angioedema, antiphospholipid antibodies and undetectable C2 levels","volume":"14","author":"Bonnin","year":"2018","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"1","key":"10.1016\/j.clim.2021.108819_bb0275","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s13223-018-0274-5","article-title":"Nine year follow-up of a rare case of angioedema due to acquired C1-inhibitor deficiency with late onset and good response to attenuated androgen","volume":"14","author":"Leru","year":"2018","journal-title":"Allergy, Asthma Clin. Immunol."},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0280","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1111\/all.13686","article-title":"Long-term effects upon rituximab treatment of acquired angioedema due to C1-inhibitor deficiency","volume":"74","author":"Levi","year":"2019","journal-title":"Allergy"},{"issue":"7","key":"10.1016\/j.clim.2021.108819_bb0285","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2019-230388","article-title":"Acquired C1-inhibitor deficiency presenting with nephrotic syndrome","volume":"12","author":"Willows","year":"2019","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.clim.2021.108819_bb0290","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.12659\/AJCR.915558","article-title":"A case of acquired angioedema with low C1 inhibitor (C1-INH) associated with splenic marginal zone lymphoma","volume":"20","author":"Abdel-Samad","year":"2019","journal-title":"Am. J. Case. Rep."},{"issue":"12","key":"10.1016\/j.clim.2021.108819_bb0295","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1159\/000509805","article-title":"Acquired angioedema due to C1 inhibitor deficiency preceding splenic marginal zone lymphoma: further insights from clinical practice","volume":"181","author":"Ferriani","year":"2020","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0300","first-page":"5","article-title":"Monoclonal gammopathy with significance: case series and literature review","volume":"78","author":"Schoot","year":"2020","journal-title":"Neth. J. Med."},{"key":"10.1016\/j.clim.2021.108819_bb0305","first-page":"1","article-title":"Acquired C1-inhibitor deficiency due to splenic marginal zone lymhoma: case report","author":"Verschueren","year":"2020","journal-title":"Acta Clin. Belg."},{"issue":"3","key":"10.1016\/j.clim.2021.108819_bb0310","article-title":"Successful use of recombinant human C1-INH in a patient with acquired angioedema due to C1 inhibitor deficiency and an unusually high titer of anti-C1-inhibitor autoantibodies","volume":"31","author":"Jesenak","year":"2020","journal-title":"J. Investig. Allergol. Clin. Immunol. [Internet]"},{"key":"10.1016\/j.clim.2021.108819_bb0315","first-page":"1","article-title":"Acquired angioedema with C1 inhibitor deficiency: occurrence, clinical features, and management: a nationwide retrospective study in the Czech Republic patients","author":"Sobotkova","year":"2021","journal-title":"Int. Arch. Allergy Immunol."},{"issue":"2","key":"10.1016\/j.clim.2021.108819_bb0320","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.jaip.2020.08.052","article-title":"The importance of complement testing in acquired angioedema related to angiotensin-converting enzyme inhibitors","volume":"9","author":"Balla","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.clim.2021.108819_bb0325","article-title":"Efficacy of lanadelumab in acquired angioedema with C1-inhibitor deficiency","volume":"S2213219821001707","author":"Belb\u00e9zier","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0330","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/joim.13182","article-title":"A follow-up survey of patients with acquired angioedema due to C1-inhibitor deficiency","volume":"289","author":"Zs","year":"2021","journal-title":"J. Intern. Med."},{"issue":"4","key":"10.1016\/j.clim.2021.108819_bb0335","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1182\/blood.V48.4.567.567","article-title":"Acquired angioedema with lymphoproliferative disorder: association of C1 inhibitor deficiency with cellular abnormality","volume":"48","author":"Schreiber","year":"1976","journal-title":"Blood"},{"issue":"3","key":"10.1016\/j.clim.2021.108819_bb0340","first-page":"523","article-title":"Acquired C1 inhibitor deficiency in a case of lymphosarcoma of the spleen. Reversal of complement abnormalities after splenectomy","volume":"37","author":"Hauptmann","year":"1979","journal-title":"Clin. Exp. Immunol."},{"issue":"6090","key":"10.1016\/j.clim.2021.108819_bb0345","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/323722a0","article-title":"An IgG autoantibody which inactivates C1-inhibitor","volume":"323","author":"Jackson","year":"1986","journal-title":"Nature"},{"issue":"3","key":"10.1016\/j.clim.2021.108819_bb0350","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/cei.13361","article-title":"Serum complexes between C1INH and C1INH autoantibodies for the diagnosis of acquired angioedema","volume":"198","author":"L\u00f3pez-Lera","year":"2019","journal-title":"Clin. Exp. Immunol."},{"issue":"1\u20132","key":"10.1016\/j.clim.2021.108819_bb0355","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.beha.2016.07.006","article-title":"Marginal zone lymphoma: associated autoimmunity and auto-immune disorders","volume":"30","author":"Teixeira Mendes","year":"2017","journal-title":"Best Pract. Res. Clin. Haematol."},{"issue":"14","key":"10.1016\/j.clim.2021.108819_bb0360","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1182\/blood-2018-04-839480","article-title":"Monoclonal gammopathy of clinical significance: a novel concept with therapeutic implications","volume":"132","author":"Fermand","year":"2018","journal-title":"Blood"},{"issue":"9","key":"10.1016\/j.clim.2021.108819_bb0365","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1111\/all.12657","article-title":"C1 inhibitor function using contact-phase proteases as target: evaluation of an innovative assay","volume":"70","author":"Ghannam","year":"2015","journal-title":"Allergy"}],"container-title":["Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162100156X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152166162100156X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T16:03:43Z","timestamp":1761494623000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152166162100156X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9]]},"references-count":73,"alternative-id":["S152166162100156X"],"URL":"https:\/\/doi.org\/10.1016\/j.clim.2021.108819","relation":{},"ISSN":["1521-6616"],"issn-type":[{"value":"1521-6616","type":"print"}],"subject":[],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Where we are with acquired angioedema due to C1 inhibitor deficiency: A systematic literature review","name":"articletitle","label":"Article Title"},{"value":"Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clim.2021.108819","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108819"}}